Follow the Silexion Therapeutics Corp share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.4m. The latest transaction was filed on 30 March 2026 (Cession). Among the most active insiders: Shirvan Mitchell. Every trade is openly available.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€26,841
1 ops.
Sell Volume
19Σ signal
Buys n/a€26,841 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Silexion Therapeutics Corp es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento de enfermedades. Cotiza en el mercado XNAS.